|
|
SAN FRANCISCO, CA / ACCESSWIRE / March 2, 2022 / Oncology Pharma Inc. OTC PINK:ONPH Oncology Pharma, Inc. "The Company" is pleased to announce progress with its investment with Ribera Solutions Connect2Med. Ribera has segregated the business entity into a separate business unit and made it an independent entity as a Delaware Corporation under the name of Connect2Trials, Inc. Oncology... Lire le communiqué |
|
| |
|
| |
|
|
SAN FRANCISCO, CA / ACCESSWIRE / February 23, 2022 / Oncology Pharma Inc. OTC PINK:ONPH Oncology Pharma, Inc. "The Company" looks toward releasing further results of the studies under the CoDevelopment Agreement with NanoSmart Pharmaceuticals, demonstrating the feasibility and the time release characteristic that is expected to improve the safety and localization profile of the... Lire le communiqué |
|
| |
|
| |
|
|
SAN FRANCISCO, CA / ACCESSWIRE / February 17, 2022 / Oncology Pharma Inc. OTC PINK:ONPH Oncology Pharma, Inc. "The Company" wants to expand on a previously announced press release that included results of formulations and data on licensed technology with NanoSmart Pharmaceuticals demonstrating the time release characteristic that is expected to improve the safety and localization... Lire le communiqué |
|
| |
|
| |
|
|
SAN FRANCISCO, CA / ACCESSWIRE / February 14, 2022 / Oncology Pharma, Inc. "The Company" OTC PINK:ONPH and Regen BioPharma, Inc. OTC PINK:RGBP and OTC PINK:RGBPP: announced that they intend to work jointly to fast track the development of therapeutic uses related to treatment in humans with pancreatic cancer of Regens patented ANTIGEN SPECIFIC MRNA CELLULAR CANCER VACCINES "MRNA... Lire le communiqué |
|
| |
|
| |
|
|
SAN FRANCISCO, CA / ACCESSWIRE / February 8, 2022 / Oncology Pharma Inc. OTC PINK:ONPH Oncology Pharma, Inc. "The Company" is pleased to announce that the codevelopment agreement and ongoing work to advance the licensed technology with Nanosmart has identified that the formulations demonstrate the timerelease characteristic that is expected to improve the safety and localization... Lire le communiqué |
|
| |
|
| |
|
|
SAN FRANCISCO, CA / ACCESSWIRE / January 10, 2022 / Oncology Pharma Inc. OTC PINK:ONPH Oncology Pharma, Inc. "The Company" update on its progress to kick off the new year.The Company has advanced its relationship and made further investment into Ribeira Solutions Connect2Med, a patient engagement platform utilizing latest available technologies. Connect2Med provides a motivating trial... Lire le communiqué |
|
| |
|
| |
|
|
SAN FRANCISCO, CA / ACCESSWIRE / December 17, 2021 / Oncology Pharma Inc. OTC PINK:ONPH Oncology Pharma, Inc. "The Company" conducted a meeting with the Board of Directors, executives, and Scientific Advisory Board members along with legal counsel, which shared updates on progress made towards the development of the Companys licensed products. This marked progress towards pursuing its... Lire le communiqué |
|
| |
|
| |
